01 1Concord Biotech
01 1PIMECROLIMUS USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-11-23
Pay. Date : 2015-09-02
DMF Number : 29658
Submission : 2015-09-15
Status : Active
Type : II
20
Concord Biotech Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PIMECROLIMUS USP, with a corresponding US DMF Number 29658.
Remarkably, this DMF maintains an Active status since its submission on September 15, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2015, and payment made on September 02, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
